INTEGRATING SYMPTOMATIC- AND DISEASE-MODIFYING TREATMENTS

被引：5

作者：

Cummings, Jeffrey L. ^{[1
,2
]}

机构：

[1] Univ Calif Los Angeles, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Deane F Johnson Ctr Neurotherapeut, Los Angeles, CA 90095 USA

来源：

CNS SPECTRUMS | 2008年 / 13卷 / 10期

关键词：

D O I：

10.1017/S1092852900027024

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：28 / 30

页数：3

共 11 条

[1] USE OF MAGNETIC RESONANCE IMAGING TO IDENTIFY MILD COGNITIVE IMPAIRMENT: WHO SHOULD BE IMAGED? [J].

Apostolova, Liana G. .

CNS SPECTRUMS, 2008, 13 (10) :18-20

[2] Changing patient characteristics and survival experience in an Alzheimer's center patient cohort [J].

Doody, R ;

Pavlik, V ;

Massman, P ;

Kenan, M ;

Yeh, S ;

Powell, S ;

Cooke, N ;

Dyer, C ;

Demirovic, J ;

Waring, S ;

Chan, WY .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 20 (2-3) :198-208

[3] Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease [J].

Doody, RS ;

Dunn, JK ;

Clark, CM ;

Farlow, M ;

Foster, NL ;

Liao, T ;

Gonzales, N ;

Lai, E ;

Massman, P .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (04) :295-300

[4] Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria [J].

Dubois, Bruno ;

Feldman, Howard H. ;

Jacova, Claudia ;

Dekosky, Steven T. ;

Barberger-Gateau, Pascale ;

Cummings, Jeffrey ;

Delocourte, Andre ;

Galasko, Douglas ;

Gauthier, Serge ;

Jicha, Gregory ;

Meguro, Kenichi ;

O'Brien, John ;

Pasquier, Florence ;

Robert, Philippe ;

Rossor, Martin ;

Solloway, Steven ;

Stern, Yaakov ;

Visser, Pieter J. ;

Scheltens, Philip .

LANCET NEUROLOGY, 2007, 6 (08) :734-746

[5] Treatment options in Alzheimer's disease: Maximizing benefit, managing expectations [J].

Farlow, Martin R. ;

Miller, Michael L. ;

Pejovic, Vojislav .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) :408-422

[6] Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study [J].

Hansson, O ;

Zetterberg, H ;

Buchhave, P ;

Londos, E ;

Blennow, K ;

Minthon, L .

LANCET NEUROLOGY, 2006, 5 (03) :228-234

[7] Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B [J].

Klunk, WE ;

Engler, H ;

Nordberg, A ;

Wang, YM ;

Blomqvist, G ;

Holt, DP ;

Bergström, M ;

Savitcheva, I ;

Huang, GF ;

Estrada, S ;

Ausén, B ;

Debnath, ML ;

Barletta, J ;

Price, JC ;

Sandell, J ;

Lopresti, BJ ;

Wall, A ;

Koivisto, P ;

Antoni, G ;

Mathis, CA ;

Långström, B .

ANNALS OF NEUROLOGY, 2004, 55 (03) :306-319

[8] FDG AND AMYLOID POSITRON EMISSION TOMOGRAPHY [J].

Mintun, Mark A. .

CNS SPECTRUMS, 2008, 13 (10) :21-24

[9] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease [J].

Rogers, SL ;

Farlow, MR ;

Doody, RS ;

Mohs, R ;

Friedhoff, LT ;

Albala, B ;

Baumel, B ;

Booker, G ;

Dexter, J ;

Farmer, M ;

Feighner, JP ;

Ferris, S ;

Gordon, B ;

Gorman, DG ;

Hanna, G ;

Harrell, LE ;

Hubbard, R ;

Kennedy, J ;

McCarthy, J ;

Scharre, DW ;

Schaerf, F ;

Schneider, L ;

Seltzer, B ;

Siegal, A ;

Stark, SR ;

Strauss, A ;

Walshe, TM .

NEUROLOGY, 1998, 50 (01) :136-145

[10] Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease [J].

Twamley, Elizabeth W. ;

Ropacki, Susan A. Legendre ;

Bondi, Mark W. .

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2006, 12 (05) :707-735

← 1 2 →